Prestige Consumer Healthcare Inc.

NYSE PBH

Prestige Consumer Healthcare Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2024: USD 353.47 M

Prestige Consumer Healthcare Inc. EBITDA is USD 353.47 M for the Trailing 12 Months (TTM) ending September 30, 2024, a 3,281.55% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Prestige Consumer Healthcare Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 10.45 M, a -97.01% change year over year.
  • Prestige Consumer Healthcare Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 349.43 M, a 7.77% change year over year.
  • Prestige Consumer Healthcare Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 324.23 M, a -1.13% change year over year.
  • Prestige Consumer Healthcare Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 327.93 M, a 247.83% change year over year.
Key data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)
Market news
Loading...
NYSE: PBH

Prestige Consumer Healthcare Inc.

CEO Mr. Ronald M. Lombardi CPA
IPO Date Feb. 10, 2005
Location United States
Headquarters 660 White Plains Road
Employees 570
Sector Health Care
Industries
Description

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

Similar companies

RGC

Regencell Bioscience Holdings Limited

USD 4.86

-4.71%

PCRX

Pacira BioSciences, Inc.

USD 20.55

-2.74%

PAHC

Phibro Animal Health Corporation

USD 20.28

0.05%

ANIP

ANI Pharmaceuticals, Inc.

USD 54.16

0.43%

SUPN

Supernus Pharmaceuticals, Inc.

USD 37.82

0.66%

COLL

Collegium Pharmaceutical, Inc.

USD 33.18

-1.80%

AMPH

Amphastar Pharmaceuticals, Inc.

USD 38.48

1.48%

StockViz Staff

January 15, 2025

Any question? Send us an email